Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Prediction of Efficacious Inhalation Lung Doses via the Use of In Silico Lung Retention Quantitative Structure-Activity Relationship Models and In Vitro Potency Screens

Anne Cooper, Tim Potter and Tim Luker
Drug Metabolism and Disposition December 2010, 38 (12) 2218-2225; DOI: https://doi.org/10.1124/dmd.110.034462
Anne Cooper
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Potter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Luker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 38 no. 12 2218-2225
DOI 
https://doi.org/10.1124/dmd.110.034462
PubMed 
20823295

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received May 14, 2010
  • Accepted September 7, 2010
  • Published online November 17, 2010.

Article Versions

  • Earlier version (September 7, 2010 - 09:58).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Anne Cooper,
  2. Tim Potter and
  3. Tim Luker
  1. AstraZeneca R&D Charnwood, Loughborough, Leicestershire, United Kingdom
  1. Address correspondence to:
    Dr. Anne E. Cooper, Discovery DMPK, AstraZeneca R&D Charnwood, Bakewell Rd., Loughborough, Leicestershire, UK LE11 5RH. E-mail: anne.cooper{at}astrazeneca.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 20171244
Sep 201703813
Oct 20170194
Nov 201713111
Dec 20171187
Jan 201853217
Feb 20181237
Mar 201803212
Apr 20180336
May 20182259
Jun 20180245
Jul 20180248
Aug 20183137
Sep 20180191
Oct 20180405
Nov 20182482
Dec 201830113
Jan 20193523
Feb 20193411
Mar 20191322
Apr 20191849
May 201913710
Jun 20191004
Jul 2019900
Aug 20192724
Oct 20191102
Nov 20191442
Dec 20191600
Jan 20201311
Feb 2020810
Mar 20201511
May 2020813
Jun 2020810
Jul 2020800
Aug 2020004
Sep 20201211
Oct 20202101
Nov 20201247
Dec 20201702
Jan 20211715
Feb 20212127
Mar 2021910
Apr 20211421
May 20215111
Jun 20212831
Jul 20211214
Aug 20211112
Sep 20211410
Oct 2021911
Nov 20212112
Dec 20213711
Jan 2022812
Feb 2022712
Mar 20221911
Apr 20222111
May 20221513
Jun 20221612
Jul 202229321
Aug 20221412
Sep 20221512
Oct 20223021
Nov 20222324
Dec 20221625
Jan 20232242
Feb 20232227
Mar 20231111

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 38 (12)
Drug Metabolism and Disposition
Vol. 38, Issue 12
1 Dec 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Prediction of Efficacious Inhalation Lung Doses via the Use of In Silico Lung Retention Quantitative Structure-Activity Relationship Models and In Vitro Potency Screens
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Prediction of Efficacious Inhalation Lung Doses via the Use of In Silico Lung Retention Quantitative Structure-Activity Relationship Models and In Vitro Potency Screens

Anne Cooper, Tim Potter and Tim Luker
Drug Metabolism and Disposition December 1, 2010, 38 (12) 2218-2225; DOI: https://doi.org/10.1124/dmd.110.034462

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Prediction of Efficacious Inhalation Lung Doses via the Use of In Silico Lung Retention Quantitative Structure-Activity Relationship Models and In Vitro Potency Screens

Anne Cooper, Tim Potter and Tim Luker
Drug Metabolism and Disposition December 1, 2010, 38 (12) 2218-2225; DOI: https://doi.org/10.1124/dmd.110.034462
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments.
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • Olanzapine Glucuronidation in Humanized Mice
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics